Abstract P2-12-14: Therapeutic mammoplasty reduces high incomplete excision rate in lobular cancer von Romics, L, Kabir, SA, Mansell, J, Mallon, EA, Stallard, S, Doughty, JC

Volltext

Evaluating HER2 amplification and overexpression in breast cancer von Bartlett, John M. S., Going, James J., Mallon, Elizabeth A., Watters, Amanda D., Reeves, Jonathan R., Stanton, Peter, Richmond, Jim, Donald, Brian, Ferrier, Rhona, Cooke, Timothy G.

Volltext

Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay von Shamis, Suad Ak, Savioli, Francesca, Ammar, Aula, Al-Badran, Sara Sf, Hatthakarnkul, Phimmada, Leslie, Holly, Mallon, Elizabeth Ea, Jamieson, Nigel B, McMillan, Donald C, Edwards, Joanne

Volltext

Abstract S4-06: HER2 status as predictive marker for AI vs Tam benefit: A TRANS-AIOG meta-analysis of 12129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2 von Bartlett, JMS, Ahmed, I, Regan, MM, Sestak, I, Mallon, EA, Dell'Orto, P, Thürlimann, BJK, Seynaeve, C, Putter, H, Brookes, CL, Forbes, JF, Colleoni, MA, Bayani, J, van de Velde, CJH, Viale, G, Cuzick, J, Dowsett, M, Rea, DW

Volltext

P3-07-30: Applying the Findings of the Z11 Trial to a UK Practice von Chalmers, CR, Mallon, EA, Stallard, S, Doughty, JC, Wilson, CR

Volltext

P1-12-05: Complete Pathological Response of Ductal Carcinoma In Situ after Treatment with Neoadjuvant Herceptin von Chalmers, CR, Mallon, EA, Touqan, N, Horgan, KJ, MacPherson, I, Doughty, JC

Volltext

Abstract P6-08-10: Disease Specific Survival of Breast Cancer Patients Is Not Associated with Expression of Inactive or Even Partially Activated Src Kinase von Elsberger, B, Tan, BA, Brown, SF, Mallon, EA, Edwards, J.

Volltext

Abstract P6-08-06: C-Reactive Protein Expression and Its Association with Disease Specific Survival and Disease Recurrence in ER Negative Breast Cancer Patients von Elsberger, B, Tannahill, C, Orange, C, Mallon, EA, Wilson, C, Doughty, JC, Edwards, J.

Volltext

Annexin A8 Is Up-Regulated During Mouse Mammary Gland Involution and Predicts Poor Survival in Breast Cancer von STEIN, Torsten, PRICE, Karen N, BRYSON, Gareth, MALLON, Elizabeth A, GUSTERSON, Barry A, MORRIS, Joanna S, HEATH, Victoria J, FERRIER, Roderick K, BELL, Alexandra K, PRINGLE, Marie-Anne, VILLADSEN, René, PETERSEN, Ole W, SAUTER, Guido

Volltext

Determination of HER2 amplification by in situ hybridization: when should chromosome 17 also be determined? von Bartlett, JM, Campbell, FM, Mallon, EA

Volltext

IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest™ in breast carcinoma von Ainsworth, R, Bartlett, J M S, Going, J J, Mallon, E A, Forsyth, A, Richmond, J, Angerson, W, Watters, A, Dunne, B

Volltext

Abstract P3-10-04: An Integration of Biological and Pathological Marker Panel in the TEAM Pathology Sub-Study: The Impact of Different Parameters on Risk Estimation of Relapse at B... von Bartlett, JMS, Stocken, D, van de Velde, CJH, Brookes, CL, Robson, T, Hasenburg, A, Hille, ETM, Kiebeck, D, Markopoulos, C, Mallon, EA, Dirix, L, Campbell, FM, Seynaeve, C, Rea, DW

Volltext

The use of proximity ligation assay to identify HER2:HER3 heterodimers in early breast cancers von Spears, M, Munro, AF, Taylor, KJ, Mallon, EA, Bartlett, JM

Volltext

Is the biology of breast cancer changing? A study of hormone receptor status and grade of breast cancers 1984-1986 and 1996-97 von Brown, SB, Mallon, EA, Edwards, J, McGlynn, LM, Campbell, FM, Timothy, CG

Volltext

Phosphorylated c-Src predicts clinical outcome in triple negative breast cancers von Elsberger, B, Tovey, SM, Tan, BA, Brown, SB, Brunton, VG, Mallon, EA, Cooke, TG, Edwards, J

Volltext

Role of Src family members in breast cancer-dependent on site of phosphorylation von Elsberger, B, Tovey, SM, Tan, BA, Brown, SB, Brunton, VG, Mallon, EA, Cooke, TG, Edwards, J

Volltext

Abstract S2-4: Final Results of a Prospectively Planned Biomarker Analysis: HER1-3 as Predictive Markers of Benefit from Early Treatment with Aromatase Inhibitors Versus Tamoxifen... von Bartlett, JMS, Brookes, CL, van de Velde, CJH, Stocken, D, Campbell, FM, Hasenburg, A, Kay, C, Kiebeck, D, Markopoulos, C, Meershoek-Klein Kranenbarg, E, Mallon, EA, Dirix, L, Robson, T, Seynaeve, C, Rea, DW

Volltext

Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status von Thomson, C.S., Twelves, C.J., Mallon, E.A., Leake, R.E.

Volltext

Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study von Stallard, Sheila, Litherland, Janet C, Cordiner, Carolyn M, Dobson, Hilary M, George, W David, Mallon, Elizabeth A, Hole, David

Volltext

Optimum number of core biopsies for accurate assessment of histological grade in breast cancer von McIlhenny, C., Doughty, J. C., George, W. D., Mallon, E. A.

Volltext